This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

NuMask Versus Traditional Mask Ventilation During Routine Care

Sponsored by Derek Sakata

About this trial

Last updated 8 years ago

Study ID

IRB_00042299

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 64 Years
All
All

Trial Timing

Ended 12 years ago

What is this trial about?

The direct objective of this study is to determine whether an experienced provider can more adequately and/or easily ventilate an anesthetized patient with the NuMask device as compared to traditional bag-valve-mask ventilation. These are approved masks, being used in the patients routine care. The researchers believe that mean tidal volumes obtained by experienced providers when manually ventilating anesthetized patients with the NuMask device will be larger than when using the traditional bag-valve-mask.

What are the participation requirements?

Yes

Inclusion Criteria

- 44 adults total

- ASA status I-III

- aged 18-64

- elective surgery at the University of Utah under general anesthesia

- Bearded, BMI >35 or edentulous

No

Exclusion Criteria

- ASA IV or higher

- Oropharyngeal or facial pathology

- Risk of aspiration (defined by need for rapid sequence intubation, uncontrolled gastroesophageal reflux disease)

- Known and/or documented difficulty placing an endotracheal tube in the past

- Limited neck extension or flexion

- Personal or familial history of malignant hyperthermia

- Known or predicted severe respiratory disease or compromise

- Pregnancy